top of page

Pfizer COVID-19 Oral Antiviral

Tue, Apr 26

|

WebEx

Learn about the Pfizer antiviral nirmatrelvir/ritonavir combination sold under the brand name Paxlovid. Speakers are Shoaib Khan, MD, Field Medical Director, North American Medical Affairs, Pfizer; and Tracy R. Wilson, DNP, MSN.Ed., RN, FNP-C, Field Medical Director, Southwest Region, Pfizer.

Registration is closed
See other events
Pfizer COVID-19 Oral Antiviral
Pfizer COVID-19 Oral Antiviral

Time & Location

Apr 26, 2022, 6:00 PM – 7:00 PM

WebEx

Guests

About the event

Nirmatrelvir is an antiviral medication developed by Pfizer which acts as an orally active 3C-like protease inhibitor. It is part of the nirmatrelvir/ritonavir combination sold under the brand name Paxlovid.

Attendees may have to download WebEx to view the presentation.

Information from Pfizer does not constitute endorsement or recommendation by MCMS.

Share this event

Subscribe today and receive MCMS Updates 

Thank you for subscribing

MCMS-Logo_Color.png

Please support the Maricopa County Medical Society Foundation:
a 501(c)(3) non-profit:

external-file_edited.png

326 East Coronado Road,  Suite 101
Phoenix, AZ 85004
Main Office: (602) 209-9867
Referral Line: (602) 252-2844

Copyright © 2025 Maricopa County Medical Society (MCMS). All rights reserved.

bottom of page